Ethics and Good Practice for Medicines

King's College LondonLondon, United Kingdom

Tuition Fee

GBP 3,975 / Per course

Start Date

Oct 27, 2026

Study Mode

On campus

Duration

5 days

You've viewed 2/5 programs/universities. You can view up to 5 programs/universities

Create a free account to unlock full content!

By registering, you agree to our Privacy Statement and Terms and Conditions.

Program Details

Degree
Courses
Major
Pharmaceutical Sciences | Pharmacology | Pharmacy
Area of study
Health
Timing
Part time
Course Language
English

Intakes

Program start date
Oct 27, 2026
Oct 27, 2027

Program Overview

Ethics and Good Practice for Medicines (7BBP0013)

Course Overview

This module provides training over five days on the concepts of ethics, good practice and risk/benefit in the development and marketing of medicines. It introduces the principles of ethics before focusing on ethical practice and the regulation of these practices.


Course Details

  • Duration: 5 days
  • Delivery mode: In person
  • Application deadline: 10 August 2025
  • Places: Available

Course Features

This course covers typical issues of ethics that arise in biomedical research and pharmaceutical medicine such as the clinical development of medicines and the commercialisation of medicines. A significant proportion of the time in this 5-day module will be devoted to discussions and workshops.


Course Content

This module aims to:


  • Enable students to critically assess the ethical principles and frameworks that impact upon the development and marketing of medicines.
  • Give students an in-depth understanding of the relevance and importance of corporate and public ethics on the development and marketing of medicines.
  • Provide an overview of the professional standards, codes and rules impacting the pharmaceutical industry (including GxP).
  • Enable students to appreciate the ethical aspects of medicine development and clinical trials (including the role and responsibilities of Ethics Committees).
  • Provide the ability to appraise the range of strategies for medicine commercialisation and their ethical consequences.

Learning Outcomes

By the end of this module students will be able to:


  • Review the concepts of ethics, good practice and risk/benefit in the development and marketing of medicines and how the industry is engaged to protect patients and the public.
  • Create multi-national clinical and commercial development programmes that apply patient involvement and operational plans, are ethical and subscribe to GxPs.
  • Critically analyse the relevant clinical and non-clinical studies that ethically justify risk/benefit.

Entry Requirements

Minimum entry requirements are either a medical degree (such as an MBBS) or a 2:1 first degree in pharmacy, pharmacology, biology, biochemistry, chemistry or related subject. The course will suit individuals seeking to develop a practical understanding of importance of ethics in medicine development and life-cycle management by the pharmaceutical industry e.g. pharmaceutical physicians, scientists in R&D and medical affairs, and regulatory affairs personnel.


Key Information

  • Course code: 7BBP0013
  • Credit level: 7
  • Credit value: 15

Fees & Discounts

  • Full Price: £1,412.00
  • International: £3,975.00

Offered by

Faculty of Life Sciences & Medicine Institute of Pharmaceutical Science Centre for Pharmaceutical Medicine


About University

Top 38Average ranking globally
View university profile

Location